High serum levels of interleukin 1β (IL-1β), IL-6, or tumor necrosis factor-α (TNF-α), often manifested during acute relapse of schizophrenia, are significantly reduced by antipsychotic therapy [9]. This evidence concerns the gene IL1B and schizophrenia.